Gentris, Shanghai Organization Partner to Push Along Personalized Medicine Initiatives | GenomeWeb

NEW YORK (GenomeWeb News) – Gentris and the Shanghai Institutes of Preventative Medicine have signed a memorandum of understanding to collaborate on personalized medicine initiatives.

Under the terms of the deal announced today, the partners will launch research projects to discover, develop, and validate new genomic biomarkers. The goal of the partnership is to create translational research and epidemiological projects and training and education programs focused on pharmacogenomics and clinical sample banking.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: transcriptional and translational study of human cytomegalovirus interactions with host cells, spider web DNA study, and more.

The New York Stem Cell Foundation signs a lease for a new space.

Researchers gear up for an international meeting to discuss the ethics of gene editing.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.